Gene Mutation and Endometrial Cancer Winston Salem NC

A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women#r3 with a highly aggressive form of the disease known as endometrioid endometrial cancer.

John S May, MD
(336) 716-4161
Medical Ctr Blvd
Winston Salem, NC
Business
John S WFUBMC
Specialties
Otolaryngology

Data Provided by:
Beverly N Jones MD
(336) 659-8817
3111 Maplewood Ave
Winston Salem, NC
Specialties
Psychiatry & Psychology

Data Provided by:
William Bryan Jennings, DO
(336) 765-1571
1900 S Hawthorne Rd
Winston Salem, NC
Business
Jennings Clinic PA
Specialties
Orthopedics

Data Provided by:
Animal Hospital Of Clemmons
(336) 766-8950
2635 Neudorf Rd
Clemmons, NC

Data Provided by:
South Main Chiropractic and Wellness
(336) 313-9953
813 S Main St
Lexington, NC

Data Provided by:
Gary G Poehling, MD
(336) 716-8200
Medical Ctr Blvd
Winston Salem, NC
Business
WFUBMC Orthopaedics
Specialties
Orthopedics

Data Provided by:
Jerome E Jennings, MD
(336) 765-1571
1900 S Hawthorne Rd
Winston Salem, NC
Business
Jennings Clinic PA
Specialties
Orthopedics

Data Provided by:
Piedmont Chiropractic Center
(336) 310-9936
851 Old Winston Rd #105
Kernersville, NC

Data Provided by:
Hillsdale Animal Hospital
(336) 998-8750
134 Medical Dr
Advance, NC

Data Provided by:
Douglas C Richards, MD
101 N Chestnut St Apt 13
Winston Salem, NC
Specialties
General Practice
Gender
Male
Education
Medical School: Oral Roberts Univ Sch Of Med, Tulsa Ok 74137
Graduation Year: 1989

Data Provided by:
Data Provided by:

Gene Mutation and Endometrial Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments.

The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women with a highly aggressive form of the disease known as endometrioid endometrial cancer.

The ATR gene directs cellular responses to DNA damage, the researchers noted.

"Women whose endometrial cancers have an ATR mutation have more than four times the risk of having their cancer return," study author Dr. Israel Zighelboim, a gynecologic oncologist, said in a news release from the university. "This and similar tumor biomarkers could potentially identify those patients most in danger of recurrence and guide the development of treatments aimed at these more aggressive tumors."

ATR mutations were found in about 5 percent of the 248 endometrioid endometrial tumor samples analyzed by the researchers. Women with ATR mutations were 4.29 times more likely to have the cancer recur after treatment and 3.88 times more likely to die.

The study appears online in the Journal of Clinical Oncology.

Zighelboim and his research colleagues plan to see if the prognostic value of ATR mutations can be confirmed in a larger group of women and to investigate the association between ATR mutations and treatment response after cancer recurrence.

More information

The American Cancer Society has more about endometrial cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com